Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans
- PMID: 7112518
- DOI: 10.1016/0049-3848(82)90312-7
Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans
Abstract
Heparan sulphate/heparin subfractions with high plasma anti-Xa activity have an unusual uronate composition, i.e. high proportions of both glucuronate and sulphated iduronate. These preparations inhibit the amidase activity of factor Xa in an uncompetitive mode and the prothrombin-activation catalyzed by Xa, both in the absence of antithrombin III. Subfractions of low affinity for antithrombin III are equally potent against Xa. The anti-X activity is destroyed by a 3-h periodate oxidation.
Similar articles
-
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.Blood. 1984 Sep;64(3):742-7. Blood. 1984. PMID: 6235872
-
Anti-factor Xa activity of heparan sulphate.Thromb Res. 1979 Feb-Mar;14(2-3):501-6. doi: 10.1016/0049-3848(79)90258-5. Thromb Res. 1979. PMID: 155896 No abstract available.
-
Anticoagulant properties in vitro of heparan sulphates.Thromb Res. 1984 Sep 1;35(5):567-76. doi: 10.1016/0049-3848(84)90288-3. Thromb Res. 1984. PMID: 6237461
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.Nouv Rev Fr Hematol (1978). 1988;30(3):155-60. Nouv Rev Fr Hematol (1978). 1988. PMID: 2971155 Review.
-
Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.Ann N Y Acad Sci. 1989;556:268-81. doi: 10.1111/j.1749-6632.1989.tb22509.x. Ann N Y Acad Sci. 1989. PMID: 2525359 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical